Total Funding
57
52
Total FundingSeed raised
Growth Score 57 in past quarter
-6 pts
Heat Score 52 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
8643
Infinimmune operates as a biotechnology company.
- Wyatt McDonnell: Co-Founder and CEO
- Anthony Slavin: Senior Vice President of Portfolio StrategyPast Role: Kymera Therapeutics, Vice President
About the Company
Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system.